Nir2-mediated MSC allows the regulation of lipids involved in the activation of the mitogen-activated protein kinase and PI3K signaling pathways, which, in turn, play an important role in the initiation and progression of breast cancer and with EMT activation (Keinan et al., 2014; Ellis and Ma, 2019). This evidence concerns the gene PITPNM1 and breast carcinoma.